Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech Inc.

9.21
+0.910010.96%
Post-market: 9.210.00000.00%19:52 EDT
Volume:87.17K
Turnover:910.13K
Market Cap:7.04M
PE:-0.37
High:10.38
Open:9.13
Low:8.50
Close:8.30
Loading ...

Hargreave Hale AIM VCT plc Cancels 237,784 Shares

TIPRANKS
·
06 Mar

Wellnex Life Secures $2.2 Million, Eyes Dual Listing on AIM

TIPRANKS
·
05 Mar

CEO Makes Bold Move with Major AIM ImmunoTech Stock Purchase

TIPRANKS
·
05 Mar

Private companies are AIM Vaccine Co., Ltd.'s (HKG:6660) biggest owners and were hit after market cap dropped HK$400m

Simply Wall St.
·
04 Mar

Viant Technology Announces Acquisition of Lockr

Business Wire
·
04 Mar

Amati AIM VCT Announces Total Voting Rights Update

TIPRANKS
·
03 Mar

Creightons PLC to Transition Shares from Main Market to AIM

TIPRANKS
·
03 Mar

RA International to Delist from AIM Following Shareholder Approval

TIPRANKS
·
01 Mar

Amati AIM VCT Appoints Maven as New Investment Manager and Expands Board

TIPRANKS
·
28 Feb

Hargreave Hale AIM VCT PLC Announces Total Voting Rights

TIPRANKS
·
28 Feb

Aim Announces Paul Goepfert, Md, as the Principal Investigator for the Planned Clinical Study of Ampligen and Flumist as a Vaccine for Avian Influenza

THOMSON REUTERS
·
28 Feb

AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza

GlobeNewswire
·
28 Feb

AIM Vaccine Eyes HK$74.7 Million from Share Placement; Shares Slide 12%

MT Newswires Live
·
28 Feb

AIM Vaccine Announces Placement of New H Shares

TIPRANKS
·
28 Feb

Morgans Keeps Their Buy Rating on Ai-Media Technologies Limited (AIM)

TIPRANKS
·
28 Feb

Hargreave Hale AIM VCT Reduces Share Capital Through Buyback

TIPRANKS
·
28 Feb

CMO Group Shares Plunge on AIM Delisting Proposal

Dow Jones
·
27 Feb

Ai-Media Technologies Ltd (ASX:AIM) (H1 2025) Earnings Call Highlights: Strategic Shift to SaaS ...

GuruFocus.com
·
27 Feb

AIM Vaccine Gets US FDA Clinical Trial Nod for Respiratory Syncytial Virus Jab

MT Newswires Live
·
27 Feb

AIM ImmunoTech Says NYSE American Accepts Plan to Regain Compliance

MT Newswires Live
·
27 Feb